1. A CROSS SECTIONAL STUDY ON THE PREVALENCE AND ASSOCIATED RISK FACTORS OF PULMONARY ARTERIAL HYPERTENSION IN CHILDREN WITH DOWN'S SYNDROME AT KENYATTA NATIONAL HOSPITAL.
- Author
-
Gatumbu, M., Jowi, C., Macharia, I., Waris, A., and Gachara, N.
- Subjects
PULMONARY arterial hypertension ,ECHOCARDIOGRAPHY ,STATISTICS ,CONFIDENCE intervals ,DOWN syndrome ,CROSS-sectional method ,CONGENITAL heart disease ,MEDICAL screening ,RISK assessment ,SEX distribution ,QUESTIONNAIRES ,DESCRIPTIVE statistics ,ODDS ratio ,DISEASE risk factors ,CHILDREN - Abstract
Background: Pulmonary arterial hypertension is a significant cause of morbidity and mortality and is associated with several risk factors in children with Down's syndrome. Objectives: To determine the prevalence and associated risk factors of pulmonary arterial hypertension in children with Down's syndrome aged 0-12 years seen at Kenyatta National Hospital. Methods: This was a cross-sectional study done over a 3-month period at KNH paediatric wards and outpatient clinics. Children with Down's syndrome aged 0-12 years were recruited into the study. Echocardiography was done on all children to assess for pulmonary arterial hypertension and congenital heart defects. Questionnaires and X-rays were used to assess for other risk factors such as adenoid hypertrophy, reflux and lung disease. Results: 81 children with Down's were enrolled in the study. The prevalence of pulmonary arterial hypertension in these children was 32.1% with 95% CI (21.0-42.0). The prevalence of congenital heart defects was 59.3%, adenoid hypertrophy: 33.3 %, pulmonary manifestations: 35.8 % and reflux disease 9.9%. The risk factors with significant association with PAH were female sex OR= 3.3 with 95% CI (1.1-10.2) and congenital heart disease OR 8.3 with 95% CI (1.9-35.8). In univariate analysis lung disease and upper airway obstruction were not associated with PAH. Conclusion and Recommendations: The prevalence of pulmonary arterial hypertension in children with Down's syndrome was 32% and was significantly associated with female gender and CHD. Early screening for pulmonary arterial hypertension and congenital heart defects is recommended in all children with Down's syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2023